Word

BASILEA PHARMACEUTICALS

Status

Pending

Status Code

730

Status Date

Friday, February 16, 2024

Serial Number

97540286

Mark Type

4000

Filing Date

Monday, August 8, 2022

Published for Opposition

Tuesday, June 27, 2023

Trademark Owner History

Basilea Pharmaceutica AG - Owner At Publication

Classifications

5 Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only

1 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

42 Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

"PHARMACEUTICALS"

Trademark Events

Feb 16, 2024

Sou Extension 1 Granted

Feb 16, 2024

Sou Extension 1 Filed

Feb 16, 2024

Sou Teas Extension Received

Aug 22, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 27, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 27, 2023

Published For Opposition

Jun 7, 2023

Notification Of Notice Of Publication E-Mailed

May 24, 2023

Approved For Pub - Principal Register

May 24, 2023

Examiner's Amendment Entered

May 24, 2023

Notification Of Examiners Amendment E-Mailed

May 24, 2023

Examiners Amendment E-Mailed

May 24, 2023

Examiners Amendment -Written

May 24, 2023

Assigned To Examiner

Aug 29, 2022

New Application Office Supplied Data Entered

Aug 11, 2022

New Application Entered